LABORATORIO FARMAC.ERFO Capital Reinvestment Ratio
LABORATORIO FARMAC.ERFO capital reinvestment ratio. LABORATORIO FARMAC.ERFO (RK7) has a Capital Reinvestment Ratio of 1.11x as of December 2023, meaning it reinvests 1% of its operating cash flow (€1.30 Million) in capital expenditures (€1.45 Million). Check cash flow reinvestment rate of LABORATORIO FARMAC.ERFO to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of LABORATORIO FARMAC.ERFO (2021–2023)
Capital reinvestment ratio of LABORATORIO FARMAC.ERFO from 2021 to 2023. This chart tracks LABORATORIO FARMAC.ERFO's Capital Reinvestment Ratio across 3 annual periods. Also explore RK7 shareholders equity momentum to track the company's year-over-year net asset growth rate.
LABORATORIO FARMAC.ERFO Capital Reinvestment Ratio by Year (2021–2023)
LABORATORIO FARMAC.ERFO capital reinvestment ratio by year from 2021 to 2023. For the full cash flow conversion analysis, see RK7 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.11x | €1.30 Million | €1.45 Million | ▼ -27.9% |
| 2022 | 1.55x | €761.80K | €1.18 Million | ▲ +1347.6% |
| 2021 | 0.11x | €2.27 Million | €242.84K | — |